Prosight Management, LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2019$2,309,000
-65.5%
587,626
+30.6%
1.28%
-62.0%
Q2 2019$6,692,000
+8.1%
450,000
+80.4%
3.37%
+24.6%
Q1 2019$6,190,000
+473.7%
249,389
+315.0%
2.71%
+386.2%
Q4 2018$1,079,000
-55.6%
60,100
+30.6%
0.56%
-63.4%
Q1 2018$2,429,000
-10.7%
46,001
+15.0%
1.52%
-23.8%
Q4 2017$2,720,00040,0002.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2019
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders